$30.00
All products are provided either as a liquid solution in a 30mL vial or as raw powder packaged in an individual bag.
80mg/ml solution (2400mg/30mL)
In the early 1990’s, researchers first synthesized RU-58841 as a novel anti-androgen which can suppress Androgen Receptor signaling [1], [2]. Early research was devoted to potential applications in the treatment of acne, but it soon became clear that its use for pathological hair thinning (ie. androgenic alopecia). Apparently owing to the success of finasteride, RU58841 was abandoned despite the positive and compelling research results showing its success in promoting hair restoration in numerous models of hair loss.
 |
|
| Clinical data | |
|---|---|
| Other names | PSK-3841; HMR-3841 |
| Drug class | Nonsteroidal antiandrogen |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H18F3N3O3 |
| Molar mass | 369.344 g·mol−1 |
| 3D model (JSmol) | |
**The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.**
